Previous close | 29.35 |
Open | 29.35 |
Bid | 26.05 |
Ask | 30.20 |
Strike | 37.50 |
Expiry date | 2026-01-16 |
Day's range | 29.35 - 29.35 |
Contract range | N/A |
Volume | |
Open interest | 12 |
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
Q1 2024 Gilead Sciences Inc Earnings Call